Health
State of Health Brazil results show China's Sinovac vaccine is just 50.4 percent effective against COVID-19
Just Earth News | @justearthnews | 14 Jan 2021, 09:56 pm Print
China COVID-19 Vaccine Brazilian clinical trials have unveiled that a COVID-19 vaccine developed by China's Sinovac has been found to be 50.4% effective, media reports said.
It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval, reports BBC.
The vaccine is one of the two which the Brazilian government has lined up.
Brazil is one of the worst-hit COVID-19 nations in the world.
Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response, reports BBC.
More Health
- First real-world evidence shows food labels and advertising bans are cutting childhood obesity
- Your blood could reveal Lung Cancer risk 5 years in advance, study finds
- The silent eye problem is growing among smartphone users — And most people don't know they have it
- What’s in your food? New figures reveal a massive global health crisis
- Shocking Case: Scientists accused of smuggling deactivated Mpox virus into America
